News

Candesic talks to HBI on care deals

1 Nov 24

At the end of October, the care homes sector across the UK and Europe saw some big news. Private equity-owned Care UK was sold by owners Bridgepoint to US REIT Welltower™ Inc. (NYSE:WELL), and Singapore-listed Parkway Life Real Estate Investment Trust (REIT) acquired 11 nursing homes from ...

Investment excitement at the Global Health Exhibition

1 Nov 24

In October, Candesic Managing Partner Dr Leonid Shapiro chaired an exciting and informative panel alongside Dr. Meshari F. Alwashmi, CEO of amplifAI health, Dr Fahad Attar, CEO of We Healthify, and Eng Basim Albeladi, MBA, CEO of لبيه | Labayh Healthcare Company, on how to successfully ...

PLife REIT has acquired 11 homes from Domusvi

1 Nov 24

Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest listed healthcare REITs, has made its maiden acquisition in Europe from Domusvi, one of Europe’s largest nursing and retirement home providers, with the acquisition of 11 nursing homes in a sale and leaseback ...

ARCHIMED has acquired FIM Medical

1 Nov 24

Global private equity healthcare specialist ARCHIMED has acquired FIM Medical, a leader in the vision, audio & respiratory medical devices market. Candesic provided ARCHIMED with commercial due diligence. The Candesic team, was led by Senior Partner Marc Kitten and supervised by Associate ...

Steady growth in dialysis

14 Oct 24

In the October edition of LaingBuisson HealthcareMarkets, Candesic Senior Marc Kitten examines the steady growth in the home dialysis market, across some of the major European markets. He also looks at some of the key dynamics in the market, particularly around patient and doctor adoption ...

Strategic issues facing pharma

8 Oct 24

Our pharmaceutical team has been discussing the strategic issues facing the pharmaceutical industry that in particular the number of drugs losing exclusivity, and the challenges and opportunities this presents.These charts examine this in more detail.

Taking the Stage on Crete – CytoReason

30 Sep 24

At the end of September, CytoReason held its CytoSummit employee conference on the beautiful island of Crete. The focus was on how to improve the probability of success in phase 2 clinical trials.Candesic Managing Partner Dr Leonid Shapiro was amongst the experts asked to provide insights into ...

The use of GenAI in clinical practice

25 Sep 24

A BMJ survey of 1,000 GPs found that twenty per cent of GPs have used GenAI in clinical practice, but according to polls we should be OK with it!The survey, published last week, said that of those GPs who used GenAI, nearly an equal number used it for differential diagnosis and generating ...

HPE Europe 2024

19 Sep 24

Candesic Senior Partner Marc Kitten has been attending HPE Europe 2024 today, which was organized by McDermott Will & Emery. The Right Honourable Rory Stewart, OBE, delivered a fascinating keynote address.In this morning's exciting session, panellists explored the future of medicine. They ...

Candesic’s Dr Marco Mazevet chairing the World Dental Federation’s annual meeting

17 Sep 24

Have you ever wondered how universal health coverage (UHC) was being implemented worldwide? Well, that was exactly what Candesic’s Dr Marco Mazevet was speaking about last week as the chair of the World Dental Federation's annual meeting in Istanbul, Turkey, in his role as Vice Chair of the ...